Evidence map›Paper›PMID 25466888›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

CXCR3 expression defines a novel subset of innate CD8+ T cells that enhance immunity against bacterial infection and cancer upon stimulation with IL-15.

Steve Oghumu, Cesar A Terrazas, Sanjay Varikuti, Jennifer Kimble, Stephen Vadia, Lianbo Yu, Stephanie Seveau, Abhay R Satoskar

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Chemokine profile in the serum of patients with leptospirosis.Frontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Th17 cells inhibit CD8Journal of hematology & oncology · 2020
    Article
  13. Article
  14. CXCR3 Identifies Human Naive CD8Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  15. Article
  16. Innate and Adaptive Immune Responses duringMicrobiology spectrum · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. NFAT2 Regulates Generation of Innate-Like CD8Frontiers in immunology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Steve Oghumu*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Cesar A Terrazas*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Sanjay Varikuti*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Jennifer Kimble*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Stephen Vadia*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Lianbo Yu*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Stephanie Seveau*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Abhay R Satoskar*Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, Ohio, USA; and Department of Microbiology, Center for Biostatistics, and Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA abhay.satoskar@osumc.edu.
The Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
Development of novel therapeutics for a neglected tropical disease leishmaniasisRC4AI092624 · NIAID · OHIO STATE UNIVERSITY · PI KINGHORN, ALAN DOUGLAS, SATOSKAR, ABHAY R · 2010 to 2010
$2.6M
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extractR21AT004160 · NCCIH · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2009 to 2010
$411k
Visualization of CXCR3 allelic usage in vivoR03AI090231 · NIAID · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2010 to 2011
$242k
Treating cutaneous leishmaniasis by radio-frequency induced heat (RFH) therapyR34AI100789 · NIAID · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2012 to 2012
$229k
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIFR03CA164399 · NCI · OHIO STATE UNIVERSITY · PI SATOSKAR, ABHAY R · 2012 to 2013
$153k
NCCIH NIH HHS R21 AT004160NCCIH NIH HHS R21-AT004160NCI NIH HHS R03 CA164399NCI NIH HHS R03-CA164399NIAID NIH HHS R03 AI090231NIAID NIH HHS R03-AI090231NIAID NIH HHS R34 AI100789NIAID NIH HHS R34-AI100789NIAID NIH HHS RC4 AI092624NIAID NIH HHS RC4-AI092624NIDCR NIH HHS T32 DE014320NIDCR NIH HHS T32DE014320
6 · The paper itself

Abstract

Innate CD8(+) T cells are a heterogeneous population with developmental pathways distinct from conventional CD8(+) T cells. However, their biology, classification, and functions remain incompletely understood. We recently demonstrated the existence of a novel population of chemokine (C-X-C motif) receptor 3 (CXCR3)-positive innate CD8(+) T cells. Here, we investigated the functional properties of this subset and identified effector molecules and pathways which mediate their function. Adoptive transfer of IL-15 activated CXCR3(+) innate CD8(+) T cells conferred increased protection against Listeria monocytogenes infection in susceptible IFN-γ(-/-) mice compared with similarly activated CXCR3(-) subset. This was associated with enhanced proliferation and IFN-γ production in CXCR3(+) cells. Further, CXCR3(+) innate cells showed enhanced cytotoxicity against a tumor cell line in vitro. In depth analysis of the CXCR3(+) subset showed increased gene expression of Ccl5, Klrc1, CtsW, GP49a, IL-2Rβ, Atp5e, and Ly6c but reduced IFN-γR2 and Art2b. Ingenuity pathway analysis revealed an up-regulation of genes associated with T-cell activation, proliferation, cytotoxicity, and translational initiation in CXCR3(+) populations. Our results demonstrate that CXCR3 expression in innate CD8(+) T cells defines a subset with enhanced cytotoxic potential and protective antibacterial immune functions. Immunotherapeutic approaches against infectious disease and cancer could utilize CXCR3(+) innate CD8(+) T-cell populations as novel clinical intervention strategies.

Indexed as

AnimalsBiomarkersBlotting, WesternCD8-Positive T-LymphocytesCell LineageCells, CulturedFemaleFlow CytometryGene Expression ProfilingImmunity, InnateInterferon-gammaInterleukin-15Listeria monocytogenesListeriosisMaleMiceBiomarkersCxcr3 protein, mouseInterferon-gammaInterleukin-15Receptors, CXCR3RNA, MessengercytokinecytotoxicitygranzymeinterferonListeria

Identifiers

PMID25466888
PMCPMC4422364
OpenAlexW2091134572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.